Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Directions.
Combining traditional chromosome testing with modern genetic sequencing improves how doctors diagnose blood cancers and choose treatments.
This review covers the evolving role of chromosome karyotyping in diagnosing hematologic cancers, from traditional G-banding to emerging technologies like optical genome mapping. It highlights how integrating cytogenetics with next-generation sequencing improves diagnostic accuracy and treatment guidance.
What the study was
- Study design
- Narrative review
- Population
- Patients with hematological malignancies (AML, CLL, MM, MDS)
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Current Medical Science
Why it surfaced
Comprehensive diagnostics review relevant to hematology watchlist. Not novel enough for HIGH but useful reference for the pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.